Opdivo (nivolumab)
pCPA File Number:
21086
Negotiation Status:
Negotiations were not pursued
Indication(s):
For the treatment of Hepatocellular Carcinoma (HCC) in adults after prior therapy
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10134
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: